These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33137324)

  • 1. P-glycoprotein deficiency enhances metabolic activation of and platelet response to clopidogrel through marked up-regulation of Cyp3a11 in mice: Direct evidence for the interplay between P-glycoprotein and Cyp3a.
    Ji JZ; Li YF; Jiang LP; Tai T; Ge PX; Mi QY; Zhu T; Xie HG
    Biochem Pharmacol; 2021 Jan; 183():114313. PubMed ID: 33137324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced metabolic activation of and platelet response to clopidogrel in T cell-deficient mice through induction of Cyp2c and Cyp3a and inhibition of Ces1.
    Jiang LP; Zhu T; Tang K; Wu Y; Fu M; Ji JZ; Mi QY; Ge PX; Zhao XH; Tai T; Xie HG
    J Thromb Haemost; 2023 May; 21(5):1322-1335. PubMed ID: 36738827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term standard alcohol consumption enhances platelet response to clopidogrel through inhibition of Nrf2/Ces1 pathway and induction of Cyp2c in mice.
    Ge PX; Jiang LP; Tai T; Zhu T; Ji JZ; Li YF; Mi QY; Xie HG
    Life Sci; 2021 Aug; 279():119268. PubMed ID: 33626394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced responsiveness of platelets to vicagrel in IL-10-deficient mice through STAT3-dependent up-regulation of the hydrolase arylacetamide deacetylase in the intestine.
    Jia YM; Zhou H; Tai T; Gu TT; Ji JZ; Mi QY; Huang BB; Li YF; Zhu T; Xie HG
    Br J Pharmacol; 2019 Jun; 176(11):1717-1727. PubMed ID: 30825385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10 does not modulate clopidogrel platelet response in mice.
    Yin Q; Tai T; Ji JZ; Mi QY; Zhang MR; Huang WJ; Cao CC; Xie HG
    J Thromb Haemost; 2016 Mar; 14(3):596-605. PubMed ID: 26712119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
    Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
    Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetes mellitus decreases systemic exposure of clopidogrel active metabolite through upregulation of P-glycoprotein in rats.
    Yao H; Gu J; Shan Y; Wang Y; Chen X; Sun D; Guo Y
    Biochem Pharmacol; 2020 Oct; 180():114142. PubMed ID: 32653591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Platelet Response to Clopidogrel in Abcc3-deficient Mice Due to Its Increased Bioactivation.
    Tai T; Mi QY; Ji JZ; Yin Q; Pan YQ; Zhang MR; Huang BB; Xie HG
    J Cardiovasc Pharmacol; 2016 Dec; 68(6):433-440. PubMed ID: 27525577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is platelet responsiveness to clopidogrel attenuated in overweight or obese patients and why? A reverse translational study in mice.
    Jiang LP; Ji JZ; Ge PX; Zhu T; Mi QY; Tai T; Li YF; Xie HG
    Br J Pharmacol; 2022 Jan; 179(1):46-64. PubMed ID: 34415054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacogenetics and pharmacodynamics of clopidogrel response: an analysis from the PRINC (Plavix Response in Coronary Intervention) trial.
    Gladding P; Webster M; Zeng I; Farrell H; Stewart J; Ruygrok P; Ormiston J; El-Jack S; Armstrong G; Kay P; Scott D; Gunes A; Dahl ML
    JACC Cardiovasc Interv; 2008 Dec; 1(6):620-7. PubMed ID: 19463375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of CYP450 Enzymes, CES1, PON1, ABCB1, and P2RY12 Polymorphisms on Clopidogrel Response in Patients Subjected to a Percutaneous Neurointervention.
    Saiz-Rodríguez M; Belmonte C; Caniego JL; Koller D; Zubiaur P; Bárcena E; Romero-Palacián D; Eugene AR; Ochoa D; Abad-Santos F
    Clin Ther; 2019 Jun; 41(6):1199-1212.e2. PubMed ID: 31128980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein, multidrug-resistance associated protein 2, Cyp3a, and carboxylesterase affect the oral availability and metabolism of vinorelbine.
    Lagas JS; Damen CW; van Waterschoot RA; Iusuf D; Beijnen JH; Schinkel AH
    Mol Pharmacol; 2012 Oct; 82(4):636-44. PubMed ID: 22767610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel.
    Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1895-900. PubMed ID: 16645157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of P2Y12 Receptor Blockers After Myocardial Infarction and Genetic Variability of their Metabolic Pathways.
    Máchal J; Hlinomaz O
    Curr Vasc Pharmacol; 2019; 17(1):35-40. PubMed ID: 29412111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-glycoprotein, CYP3A, and plasma carboxylesterase determine brain and blood disposition of the mTOR Inhibitor everolimus (Afinitor) in mice.
    Tang SC; Sparidans RW; Cheung KL; Fukami T; Durmus S; Wagenaar E; Yokoi T; van Vlijmen BJ; Beijnen JH; Schinkel AH
    Clin Cancer Res; 2014 Jun; 20(12):3133-45. PubMed ID: 24727322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-glycoprotein Limits Ribociclib Brain Exposure and CYP3A4 Restricts Its Oral Bioavailability.
    Martínez-Chávez A; van Hoppe S; Rosing H; Lebre MC; Tibben M; Beijnen JH; Schinkel AH
    Mol Pharm; 2019 Sep; 16(9):3842-3852. PubMed ID: 31329454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced Platelet Response to Clopidogrel in Zucker Diabetic Fatty Rats due to Impaired Clopidogrel Inactivation by Carboxylesterase 1 and Increased Exposure to Active Metabolite.
    Yao H; Bai R; Ren T; Wang Y; Gu J; Guo Y
    Drug Metab Dispos; 2019 Aug; 47(8):794-801. PubMed ID: 31092394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response.
    Harmsze AM; Robijns K; van Werkum JW; Breet NJ; Hackeng CM; Ten Berg JM; Ruven HJ; Klungel OH; de Boer A; Deneer VH
    Thromb Haemost; 2010 May; 103(5):920-5. PubMed ID: 20352154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-Glycoprotein (MDR1/ABCB1) Restricts Brain Penetration of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib, While Cytochrome P450-3A (CYP3A) Limits Its Oral Bioavailability.
    van Hoppe S; Rood JJM; Buil L; Wagenaar E; Sparidans RW; Beijnen JH; Schinkel AH
    Mol Pharm; 2018 Nov; 15(11):5124-5134. PubMed ID: 30247919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dextran sulfate sodium-induced colitis and ginseng intervention altered oral pharmacokinetics of cyclosporine A in rats.
    Yang Y; Hu N; Gao XJ; Li T; Yan ZX; Wang PP; Wei B; Li S; Zhang ZJ; Li SL; Yan R
    J Ethnopharmacol; 2021 Jan; 265():113251. PubMed ID: 32810615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.